Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline

Trump hints at major tariffs on foreign pharmaceuticals, sparking concerns for Indian suppliers and potential hikes in U.S. drug costs.

Latest Ratings for PFE

DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Jan 2022Wells FargoMaintainsOverweight Jan 2022B of A SecuritiesUpgradesNeutralBuy

View More Analyst Ratings for PFE

View the Latest Analyst Ratings

read more